Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of the newspaper publications of the un-audited financial results for the quarter and nine months ended December 31, 202113-02-2022
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of the newspaper publications of the un-audited financial results for the quarter and nine months ended December 31, 2021Nureca Ltd - 543264 - Appointment Of Director
Appointment of Mr. Sushil Kumar Bhardwaj (DIN 09468448) as an Additional Director & Whole-time Director of the Company designated as Director - Compliance for a period of three years with effect from February 12, 2022.Nureca Ltd - 543264 - Statement Of Deviation And Variation
Statement of Deviation and VariationNureca Ltd - 543264 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board MeetingNureca Ltd - 543264 - Board to consider Interim Dividend
Nureca Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 12, 2022, to consider and approve, inter-alia, the Unaudited Financial Results (Standalone and Consolidated) for the third quarter and nine months ended December 31, 2021.Further, the Board may also consider the proposal for declaration of Interim Dividend on equity shares of the Company at the aforesaid Board Meeting.Further, refer to the Company''s letter dated December 23, 2021, wherein it was informed that pursuant to the Company''s "Conduct for Prevention of Insider Trading", the trading window for dealing in Equity shares of the Company shall remain closed from December 24, 2021 in view of the declaration of un-audited financial results of the Company for the third quarter and nine months ended December 31, 2021.Further, the trading window shall remain closed from December 24, 2021 to February 14, 2022 (both days inclusive).Nureca Ltd - 543264 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) For The Third Quarter And Nine Months Ended December 31, 2021.
Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2022 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the third quarter and nine months ended December 31, 2021. Further, the Board may also consider the proposal for declaration of Interim Dividend on equity shares of the Company at the Board Meeting.Nureca Ltd - 543264 - Shareholding for the Period Ended December 31, 2021
Nureca Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click hereNureca Ltd - 543264 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Chetna AnandDesignation :- Company Secretary and Compliance OfficerNureca Ltd - 543264 - Clarification On Increase In Volume
Please find enclosed reply letter on "Clarification on Increase in Volume"